Epigenetic susceptibility factors for prostate cancer with aging.
about
Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysisDoes epigenetic drift contribute to age-related increases in breast cancer risk?Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancerImpact of a folic acid-enriched diet on urinary tract function in mice treated with testosterone and estradiol.DNA methylation as a dynamic regulator of development and disease processes: spotlight on the prostateEarly treatment with metformin induces resistance against tumor growth in adult rats.Genomic Profiling Reveals Unique Molecular Alterations in Hepatoblastomas and Adjacent Hepatocellular Carcinomas in B6C3F1 Mice.Methylation of Apoptosis-Associated Speck-Like Protein With a Caspase Recruitment Domain and Outcomes in Heart Failure.HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.Polyomavirus BK and prostate cancer: an unworthy scientific effort?Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.Addressing the need for repeat prostate biopsy: new technology and approaches.Knockdown of GPR137,G Protein-coupled receptor 137, Inhibits the Proliferation and Migration of Human Prostate Cancer Cells.The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.Evaluation of individual aging degree by standard-free, label-free LC-MS/MS quantification of formaldehyde-modified peptides.Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.Markers as mediators: A review and synthesis of epigenetics literature
P2860
Q33814787-C104FFA9-84CD-41CB-99CB-0A24A21E315DQ34533343-643EB7DD-1C93-49FD-9DBA-A96750EEB489Q35022469-F0EC1851-2558-4693-9C52-44FA45188563Q35749673-054F8883-9E35-4567-8019-CD71B2EB0E25Q35847749-BB738886-22BC-4AF6-B53E-4A857748AD95Q36215473-A98B0904-EF68-41F1-82CF-97CC8FFC8674Q36348318-1D939DA4-157C-4E7F-BD4B-CB4774AFC443Q36885431-F3A12F17-DD03-4166-A478-0CB9CB9653F6Q37582166-BF0C5C36-754C-4D20-B999-82CD38594892Q38269155-2427FDBA-6637-43BC-981F-0EC91E036CE7Q38320502-A8EA306C-D26D-4E85-A950-3C38AE7CB582Q38392009-C04DA00D-FB47-4D42-8931-3903F720E68EQ38546671-8B7B525E-BB47-40A7-96FB-1DB014166F4DQ38811671-409DE404-D70C-4144-A464-3C57FB66C7F7Q39401758-71562032-4E74-4A74-80FE-137B9A3A2F26Q41023958-B1821BCB-69C9-48F7-A8B4-318F75A387C3Q47295153-462C9FC6-B7AF-4FB5-A573-8424B0F02229Q57261659-A8ED1D3C-B690-459B-8646-B178E62466FE
P2860
Epigenetic susceptibility factors for prostate cancer with aging.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Epigenetic susceptibility factors for prostate cancer with aging.
@ast
Epigenetic susceptibility factors for prostate cancer with aging.
@en
Epigenetic susceptibility factors for prostate cancer with aging.
@nl
type
label
Epigenetic susceptibility factors for prostate cancer with aging.
@ast
Epigenetic susceptibility factors for prostate cancer with aging.
@en
Epigenetic susceptibility factors for prostate cancer with aging.
@nl
prefLabel
Epigenetic susceptibility factors for prostate cancer with aging.
@ast
Epigenetic susceptibility factors for prostate cancer with aging.
@en
Epigenetic susceptibility factors for prostate cancer with aging.
@nl
P2093
P2860
P356
P1433
P1476
Epigenetic susceptibility factors for prostate cancer with aging
@en
P2093
P2860
P304
P356
10.1002/PROS.22716
P577
2013-09-02T00:00:00Z